FDAnews
www.fdanews.com/articles/61807-correction

CORRECTION

August 17, 2006

Celsion's Prolieve thermodilatation disposable catheter system discussed in an article in the Aug. 15 issue of Device Daily Bulletin, "Celsion Prostate Cancer Catheter Kits Back on the Market," is for treating benign prostatic hyperplasia. Changes in Celsion's manufacturing and inspection processes for the system were identified and initiated by the firm and the FDA approved implementation of the changes.